FDA Adverse Event Other Summary report: N

ALARIS INFUSION SET

MDR report key: 20980101 · Received December 18, 2024

Report

Report Number
MW5163754
Event Type
Other
Date Received
December 18, 2024
Date of Event
December 10, 2024
Report Date
December 13, 2024
Manufacturer
BD/CAREFUSION 2200, INC.
Product Code
FPA
Report Source
Voluntary report
Reporter Location
SC, US
Reporter Occupation
RISK MANAGER
Health Professional
Yes

Narratives

Description of Event or Problem · 0

UPON REMOVING THE INFUSION TUBING FROM THE PACKAGING A BLACK RESIDUE WAS NOTED IN THE CAP. THE SET WAS NOT USED ON A PATIENT. ANOTHER TUBING SET WAS OBTAINED AND USED FOR THE PATIENT. BD ALARIS INFUSION SET 24045578.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
2151679 ALARIS INFUSION SET SET, ADMINISTRATION, INTRAVASCULAR FPA BD/CAREFUSION 2200, INC. 24045578

Patients

Seq Age Sex Outcome Treatment
1 NA Unknown Other